- We will send in 10–14 business days.
/images/books/13696315/9789533070162.jpg)
- Publisher: IntechOpen
- ISBN-10: 9533070161
- ISBN-13: 9789533070162
- Format: 17 x 24.4 x 2.2 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Neuroblastoma (e-book) (used book) | bookbook.eu
Reviews
Description
Neuroblastoma, once called "enigmatic", due to "unpredictable" clinical behaviors, is composed of biologically diverse tumors. Molecular/genomic properties unique to the individual tumors closely link to the clinical outcomes of patients. Establishing risk stratification models after analyzing biologic characteristics of each case has made a great success in patient management. However, the trend of improving survival rates in neuroblastoma over the last 30 years has started to level off, and currently available treatment modalities have almost reached to their maximized intensity. Furthermore, aggressive treatment causes significant long-term morbidities to the survivors. We really need to make the next step to the level of personalized medicine with more precise understanding of neuroblastoma biology. This book includes useful data and insights from the world's experts in this field. I believe this book can make an excellent contribution to all the investigators working hard and fighting for the children stricken by this disease.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 17d.16:28:31
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: IntechOpen
- ISBN-10: 9533070161
- ISBN-13: 9789533070162
- Format: 17 x 24.4 x 2.2 cm, hardcover
- Language: English English
Neuroblastoma, once called "enigmatic", due to "unpredictable" clinical behaviors, is composed of biologically diverse tumors. Molecular/genomic properties unique to the individual tumors closely link to the clinical outcomes of patients. Establishing risk stratification models after analyzing biologic characteristics of each case has made a great success in patient management. However, the trend of improving survival rates in neuroblastoma over the last 30 years has started to level off, and currently available treatment modalities have almost reached to their maximized intensity. Furthermore, aggressive treatment causes significant long-term morbidities to the survivors. We really need to make the next step to the level of personalized medicine with more precise understanding of neuroblastoma biology. This book includes useful data and insights from the world's experts in this field. I believe this book can make an excellent contribution to all the investigators working hard and fighting for the children stricken by this disease.
Reviews